tradingkey.logo

Canadian fuel refiner and retailer Parkland's Q3 revenue beats estimates

ReutersOct 27, 2025 11:58 AM


Overview

  • Parkland Q3 revenue of C$7.35 bln beats analyst expectations

  • Adjusted EBITDA for Q3 2025 beats estimates, reaching C$540 mln

  • Sunoco transaction expected to close on October 31, 2025


Outlook

  • Parkland on track to meet midpoint of 2025 Adjusted EBITDA guidance of C$1.8 to C$2.1 bln

  • Parkland shares to be delisted from TSX; SunocoCorp Units to trade on NYSE Nov 3


Result Drivers

  • REFINING MARGINS - Higher refining margins and strong utilization at Burnaby Refinery boosted results

  • CANADA SEGMENT - Stronger fuel unit margins and marketing initiatives in Canada drove growth

  • INTERNATIONAL GROWTH - Volume growth in retail and commercial businesses supported International segment


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

C$7.35 bln

C$7.01 bln (3 Analysts)

Q3 EPS

C$0.73

Q3 Adjusted Net Income

Beat

C$180 mln

C$119.985 mln (1 Analyst)

Q3 Net Income

C$129 mln

Q3 Adjusted EBITDA

Beat

C$540 mln

C$493.4 mln (8 Analysts)

Q3 Basic EPS

C$0.74


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the oil & gas refining and marketing peer group is "hold."

  • Wall Street's median 12-month price target for Parkland Corp is C$44.00, about 7.6% above its October 24 closing price of C$40.65

  • The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 13 three months ago

Press Release: ID:nCNWt28jfa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI